ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,280Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 887

$446K Total Retail Price of All Prescriptions

Rank: 50 out of 887

428 Patients Receiving at Least One Drug in Part D
40%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 428 patients filled at least one prescription for a schedule two drug, compared to an average of 13%.

Schedule Three
Controlled Substances

21% of this provider’s 428 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 2,756 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 319 79 1 2
TRAMADOL HCL 256 88 2 15
ZOLPIDEM TARTRATE 242 124 3 14
HYDROCODONE-ACETAMINOPHEN 231 87 S3 4 1
FUROSEMIDE 221 136 5 7
LEVOTHYROXINE SODIUM 175 64 6 9
NEXIUM 149 41 7 18
LISINOPRIL 139 92 8 4
METFORMIN HCL 128 48 9 8
PROMETHAZINE HCL 124 22 R 10 69
PROAIR HFA 122 46 11 39
TIZANIDINE HCL 117 14 12 48
GABAPENTIN 116 14 13 6
FLUOXETINE HCL 110 22 14 62
AMLODIPINE BESYLATE 89 59 15 5
COMBIVENT 87 36 16 129
SERTRALINE HCL 86 27 17 32
GLIMEPIRIDE 85 46 18 54
HYDROCHLOROTHIAZIDE 83 38 19 10
ROPINIROLE HCL 82 26 20 93
TRAZODONE HCL 80 24 21 27
FENOFIBRATE 78 34 22 87
SIMVASTATIN 77 61 23 3
CLOPIDOGREL 74 47 24 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 25 24 22
METOPROLOL TARTRATE 73 36 26 16
ADVAIR DISKUS 67 20 27 55
FAMOTIDINE 64 34 28 143
PRAVASTATIN SODIUM 63 20 29 12
LANTUS 59 21 30 97
WARFARIN SODIUM 59 29 30 26
KLOR-CON M20 58 49 32 127
LANTUS SOLOSTAR 58 14 32 86
PANTOPRAZOLE SODIUM 57 20 34 47
LYRICA 56 20 35 49
TOPIRAMATE 56 14 35 74
CYCLOBENZAPRINE HCL 56 0 R 35 35
METOPROLOL SUCCINATE 55 49 38 19
CLONIDINE HCL 53 16 39 76
SPIRIVA 52 25 40 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.